EUVIMEDEUVIMED entdecken
Fallbericht

Characterization of a Novel Variant in the NR3C1 Gene: Differentiating Glucocorticoid Resistance From Cushing Syndrome

Margaux Laulhé, Michal Yacobi Bach, Julie Perrot, Michal Gershinsky, Jérôme Fagart, Gabi Shefer, Larbi Amazit, Peter Kamenický, Say Viengchareun, Laetitia Martinerie, Yona Greenman iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae829 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Margaux Laulhé und 10 weiteren Autor:innen. Beteiligte Einrichtung: Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, Le Kremlin-Bicêtre 94276, France. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Cushing Syndrome, Metabolism, Inborn Errors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Inserm, Université Paris-Saclay, ITMO Cancer of Aviesan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Primary generalized glucocorticoid resistance syndrome (GGRS) is a rare endocrine disease caused by loss-of-function variants of the NR3C1 gene encoding the glucocorticoid receptor (GR).

Objective

We describe a novel heterozygous missense variant (NM_000176.3, c.1330T>G, p.Phe444Val) within the DNA-binding domain. Clinical Case Elevated urinary free cortisol levels were detected in a 59-year-old male patient before bariatric surgery (body mass index 39.9 kg/m2). Early-onset hypertension was well controlled. The low-dose dexamethasone suppression test was pathologic, but ACTH and midnight salivary cortisol levels were normal. The patient was initially referred to transsphenoidal surgery for a presumed diagnosis of Cushing disease. He presented to our department at the age of 68, when the clinical diagnosis of GGRS was established.

Methods

Functional characterization of the variant was performed ex vivo through transient transfection assays in HEK 293T cells to assess transcriptional activity and nuclear translocation.

Results

The variant showed a lack of transcriptional activity (GRWT: 91.5 [80.5; 101.2] vs GRF444V: 1.0 [1.0; 1.0]) despite efficient nuclear translocation in response to dexamethasone, suggesting a DNA binding defect of the variant. These results are discussed in the light of previously reported GGRS cases.

Conclusion

We have described a novel heterozygous mutation of the NR3C1 gene associated with primary GGRS. This case highlights the importance of raising awareness of clinical and laboratory features of this rare disorder, to enable early diagnosis and avoid unnecessary and potentially dangerous diagnostic and therapeutic procedures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GlucocorticoidCushing SyndromeMetabolism, Inborn ErrorsHumansMaleMiddle AgedMutation, MissenseDiagnosis, DifferentialHEK293 CellsGlucocorticoids

Stichwörter der Autor:innen

NR3C1 geneglucocorticoid receptorglucocorticoid resistance syndrome

Substanzen

Receptors, GlucocorticoidNR3C1 protein, humanGlucocorticoids

Autor:innen und Institutionen

  • Physiologie et Physiopathologie Endocriniennes, Université Paris-Saclay, Inserm, Le Kremlin-Bicêtre 94276, France.
  • Institute of Endocrinology, Diabetes, Metabolism and Hypertension, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
  • Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
  • Department of Endocrinology and Diabetes, Lady Davis Carmel Medical Center and Linn Medical Center, Clalit Health Services, Haifa 3515210, Israel.
  • Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 32000, Israel.
  • CNRS UMR 7654, Ecole Polytechnique, Palaiseau 91120, France.

ORCID-Profile: Yona Greenman

Förderung

  • Inserm
  • Université Paris-Saclay
  • ITMO Cancer of Aviesan

Zitieren

APA

Laulhé, M., Yacobi Bach, M., Perrot, J., Gershinsky, M., Fagart, J., Shefer, G., Amazit, L., Kamenický, P., Viengchareun, S., Martinerie, L., & Greenman, Y. (2025). Characterization of a Novel Variant in the NR3C1 Gene: Differentiating Glucocorticoid Resistance From Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae829

Vancouver

Laulhé M, Yacobi Bach M, Perrot J, Gershinsky M, Fagart J, Shefer G, et al. Characterization of a Novel Variant in the NR3C1 Gene: Differentiating Glucocorticoid Resistance From Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae829

BibTeX
@article{Laulh2025,
  author = {Laulhé, Margaux and Yacobi Bach, Michal and Perrot, Julie and Gershinsky, Michal and Fagart, Jérôme and Shefer, Gabi and Amazit, Larbi and Kamenický, Peter and Viengchareun, Say and Martinerie, Laetitia and Greenman, Yona},
  title = {Characterization of a Novel Variant in the NR3C1 Gene: Differentiating Glucocorticoid Resistance From Cushing Syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae829}
}
Kostenlos starten →